Madrigal Pharmaceuticals (MDGL) Research Hub

Madrigal Pharmaceuticals (MDGL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 437.74 USD (+0.81%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -42.00, market cap 12.51B. This hub links to the full technical, earnings and options research available for MDGL.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close437.74 USD (+0.81%)
52-week range432.12 USD – 569.44 USD
Trend regimeRange
14-day RSI26 (Oversold)
Trailing P/E-42.00
Market cap12.51B
Dividend yield0.00%
Next earnings2026-07-30

Available research for MDGL

Earnings

MDGL earnings date and last-quarter result: next report 2026-07-30, last quarter miss, P/E -42.00. Updated 2026-07-23.

Options: Covered Call

Covered Call on MDGL: how it works, illustrative setup around the real 437.74 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on MDGL: how it works, illustrative setup around the real 437.74 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on MDGL: how it works, illustrative setup around the real 437.74 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

MDGL technical analysis: range, last 437.74 USD, RSI 26, 52w range 432.12 USD–569.44 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is MDGL in?

Madrigal Pharmaceuticals (MDGL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is MDGL in an uptrend or downtrend?

As of 2026-10-26, MDGL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is MDGL's trailing P/E ratio?

MDGL's trailing P/E is -42.00, with a market cap of 12.51B. See the earnings research page for full valuation detail.

When does MDGL next report earnings?

MDGL is next scheduled to report earnings on 2026-07-30.